[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ironheart Capital [@Ironheart_Cap](/creator/twitter/Ironheart_Cap) on x XXX followers Created: 2025-07-26 13:13:32 UTC Is UNH a Buy? Let’s Talk About the $400B Elephant in the ER. Happy Satruday-buckle up, this one’s spicy. So here’s the deal. July XX is the make-or-break moment for UnitedHealth Group (UNH)-the biggest name in health insurance and, right now, one of the biggest dumpster fires in the DIA. Seriously, the healthcare sector has been beat to all fuck. You’d think it got diagnosed with stage X margin compression. But let’s talk UNH specifically. The stock’s down over XX% from the highs. Yes, fifty. For a blue-chip, cash-printing juggernaut. So the question is-is this a buy, or is this a “stay far away until the lawsuits stop flying” situation? Let’s break it down. Cause I wanted to know so chances are you may as well. The CEO Left the Building. So… What Now? Andrew Witty stepped down. No big farewell tour. Just dipped. Enter Stephen Hemsley, the guy who already ran UNH in its golden era. And he didn’t come back as a figurehead-he’s in it for three years, got a $1M salary, and-here’s the kicker-a $XX million stock option package if he pulls this turnaround off. So yeah, he’s got real skin in the game. If the stock doesn’t bounce back. Politicians Are Buying the Dip… Look-I don’t love political stock trades. But when multiple members of Congress start buying shares after the earnings crash… might be a good idea to take notice. Rep. Michael McCaul: Bought twice, $50K–$100K each Rep. Marjorie Taylor Greene: Bought $15K–$50K Rep. Gil Cisneros: Bought $10K–$15K Rep. Scott Franklin: Same Why would they do that? Either they’re insane… or they think July XX will clear the fog and send this thing back to a more reasonable evaluation. Maybe both. But I’m watching it. Insiders Are Loading Up: You know who else bought big? Stephen Hemsley himself-$25 million. Other execs? Over $5M combined. Nobody’s buying options. They’re buying shares-like “I want in at this price” shares. Call me old-fashioned, but when insiders buy after a XX% crash, I listen. Why It Crashed in the First Place: Let’s not sugarcoat it. UNH face-planted for a reason: They missed earnings hard. Suspended 2025 guidance completely. Got hit with a DOJ criminal probe AND Medicare Advantage audits. And Witty peaced out right when the plane hit turbulence. It’s been ugly. And the market HATES uncertainty more than anything. So naturally… sell button go weeeee. The Numbers: Still a Beast Now here’s where it gets interesting. - 2024 Revenue: $XXX billion - 2025 Estimates: ~$460 billion - 2026 Estimates: ~$491 billion - 2027 (revised): $XXX billion - Free Cash Flow: ~$11B this quarter So even after shaving down guidance, this is still a company that prints money like it’s running a side hustle for the Fed. We’re not talking about some small-cap biopharma hoping for a miracle trial. This is United. Health. Group. Also, it’s trading at a P/E of XXXX with a PEG ratio under X. For context, that’s cheap. Like “holy fuck” cheap. - Lawsuits and Legal Drama: - Here’s the cloud hanging over all of this. - DOJ is poking around for fraud. - CMS is auditing their Medicare Advantage billing. States are suing over ACA rules that could mess with enrollment numbers. Worst case? A fat fine and tighter margins. Best case? They settle and keep raking in billions like they always have. What Happens on July 29? This is the day UNH finally gives guidance. They’ll talk 2025 revenue. They’ll hint at 2026. They’ll likely beg Wall Street to calm down. And if that narrative sticks? Boom. You could see a snapback rally that’d make short sellers cry. If they fumble again? You’re probably staring at $XXX. So… Buy It? Here’s my take: If you like turnarounds, this is a good one. If you follow the money, insiders and politicians are loading up. If you’re scared of lawsuits, maybe wait for the dust to settle. But ask yourself this-how often do you get to buy a $400B company with actual growth, real cash flow, and political backing at this kind of valuation? It’s a coin flip. But the upside is juicy. Final autistic ramblings: I don't know if UNH isn’t a long-term “set it and forget it” stock right now. It’s a risk-reward trade. If July XX goes well? You look like a genius. If it doesn’t? You’re holding a hot potato. Either way, keep your eyes on the prize-and keep your charts open Tuesday morning. And here's a picture of Sydney Sweeney as a nurse. You're welcome. Happy Saturday. ~ IHC  XXX engagements  **Related Topics** [coins healthcare](/topic/coins-healthcare) [dia](/topic/dia) [fires](/topic/fires) [insurance](/topic/insurance) [unitedhealth group](/topic/unitedhealth-group) [elephant](/topic/elephant) [$400b](/topic/$400b) [$unh](/topic/$unh) [Post Link](https://x.com/Ironheart_Cap/status/1949095746109616275)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ironheart Capital @Ironheart_Cap on x XXX followers
Created: 2025-07-26 13:13:32 UTC
Is UNH a Buy? Let’s Talk About the $400B Elephant in the ER.
Happy Satruday-buckle up, this one’s spicy.
So here’s the deal. July XX is the make-or-break moment for UnitedHealth Group (UNH)-the biggest name in health insurance and, right now, one of the biggest dumpster fires in the DIA.
Seriously, the healthcare sector has been beat to all fuck. You’d think it got diagnosed with stage X margin compression. But let’s talk UNH specifically.
The stock’s down over XX% from the highs. Yes, fifty. For a blue-chip, cash-printing juggernaut. So the question is-is this a buy, or is this a “stay far away until the lawsuits stop flying” situation?
Let’s break it down. Cause I wanted to know so chances are you may as well.
The CEO Left the Building. So… What Now?
Andrew Witty stepped down. No big farewell tour. Just dipped.
Enter Stephen Hemsley, the guy who already ran UNH in its golden era. And he didn’t come back as a figurehead-he’s in it for three years, got a $1M salary, and-here’s the kicker-a $XX million stock option package if he pulls this turnaround off.
So yeah, he’s got real skin in the game. If the stock doesn’t bounce back.
Politicians Are Buying the Dip…
Look-I don’t love political stock trades. But when multiple members of Congress start buying shares after the earnings crash… might be a good idea to take notice.
Rep. Michael McCaul: Bought twice, $50K–$100K each Rep. Marjorie Taylor Greene: Bought $15K–$50K Rep. Gil Cisneros: Bought $10K–$15K Rep. Scott Franklin: Same
Why would they do that? Either they’re insane… or they think July XX will clear the fog and send this thing back to a more reasonable evaluation. Maybe both. But I’m watching it.
Insiders Are Loading Up:
You know who else bought big?
Stephen Hemsley himself-$25 million.
Other execs? Over $5M combined.
Nobody’s buying options. They’re buying shares-like “I want in at this price” shares.
Call me old-fashioned, but when insiders buy after a XX% crash, I listen.
Why It Crashed in the First Place:
Let’s not sugarcoat it. UNH face-planted for a reason: They missed earnings hard.
Suspended 2025 guidance completely.
Got hit with a DOJ criminal probe AND Medicare Advantage audits.
And Witty peaced out right when the plane hit turbulence.
It’s been ugly. And the market HATES uncertainty more than anything. So naturally… sell button go weeeee.
The Numbers: Still a Beast
Now here’s where it gets interesting.
2024 Revenue: $XXX billion
2025 Estimates: ~$460 billion
2026 Estimates: ~$491 billion
2027 (revised): $XXX billion
Free Cash Flow: ~$11B this quarter
So even after shaving down guidance, this is still a company that prints money like it’s running a side hustle for the Fed. We’re not talking about some small-cap biopharma hoping for a miracle trial. This is United. Health. Group.
Also, it’s trading at a P/E of XXXX with a PEG ratio under X. For context, that’s cheap. Like “holy fuck” cheap.
Lawsuits and Legal Drama:
Here’s the cloud hanging over all of this.
DOJ is poking around for fraud.
CMS is auditing their Medicare Advantage billing.
States are suing over ACA rules that could mess with enrollment numbers. Worst case? A fat fine and tighter margins. Best case? They settle and keep raking in billions like they always have.
What Happens on July 29?
This is the day UNH finally gives guidance. They’ll talk 2025 revenue. They’ll hint at 2026. They’ll likely beg Wall Street to calm down. And if that narrative sticks? Boom. You could see a snapback rally that’d make short sellers cry.
If they fumble again? You’re probably staring at $XXX.
So… Buy It?
Here’s my take:
If you like turnarounds, this is a good one. If you follow the money, insiders and politicians are loading up.
If you’re scared of lawsuits, maybe wait for the dust to settle.
But ask yourself this-how often do you get to buy a $400B company with actual growth, real cash flow, and political backing at this kind of valuation?
It’s a coin flip. But the upside is juicy.
Final autistic ramblings:
I don't know if UNH isn’t a long-term “set it and forget it” stock right now. It’s a risk-reward trade. If July XX goes well? You look like a genius. If it doesn’t? You’re holding a hot potato.
Either way, keep your eyes on the prize-and keep your charts open Tuesday morning.
And here's a picture of Sydney Sweeney as a nurse. You're welcome.
Happy Saturday. ~ IHC
XXX engagements
Related Topics coins healthcare dia fires insurance unitedhealth group elephant $400b $unh